Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke

Neurology

Volumn 64, Issue 12, 2005, Pages 2115-2120

  Qureshi, A I ^a,c,d   Kirmani, J F ^a   Sayed, M A ^b   Safdar, A ^a   Ahmed, S ^a   Ferguson, R ^c   Hershey, L A ^c   Qazi, K J ^d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d DOC 8100 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRINKING BEHAVIOR; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; SYMPTOM; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NEW YORK; PATIENT ADMISSION; PATIENT DISCHARGE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 21144449813     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000165951.03373.25     Document Type: Review

References (31)

1. American Stroke Association. A Division of American Heart Association. 2001 Heart and stroke statistical update. www.americanheart.org/ statistics/stroke.html; accessed 01/08/02.
2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
3. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-2011.
4. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2003;3: CD000213.
5. Daley S, Braimah J, Sailor S, et al. Education to improve stroke awareness and emergent response. The NINDS rt-PA Stroke Study Group. J Neurosci Nurs 1997;29:393-396.
6. Qureshi AI, Kirmani JF, Sayed MA, et al. Buffalo Metropolitan Area and Erie County Stroke Study: rationale, design, and methods. Neuroepidemiology 2004;23:289-298.
7. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21:637-676.
8. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-380.
9. Sacco SE, Whisnant JP, Broderick JP, Phillips SJ, O'Fallon WM. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991;22:1236-1241.
10. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992;23:1250-1256.
11. Brott TG, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870.
12. Williams LS, Yilmaz EY, Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 2000;31:858-862.
13. Wolfe CD, Taub NA, Woodrow EJ, et al. Assessment of scales of disability and handicap in stroke patients. Stroke 1991;22:1242-1244.
14. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA. The OSF Stroke Network experience. Stroke 2000;31:77-81.
15. Chapman KM, Woolfenden AR, Graeb D, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital's experience. Stroke 2000;31:2920-2924.
16. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151-1158.
17. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015-1020.
18. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-2013.
19. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003;34:799-800.
20. Katzan IL, Graber TM, Furlan AJ, et al. Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets. Stroke 2003;34:994-998.
21. Brown DL, Lisabeth LD, Garcia NM, et al. Emergency department evaluation of ischemic stroke and TIA: the BASIC project. Neurology 2004;63:2250-2254.
22. Azzimondi G, Bassein L, Fiorani L, et al. Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. Stroke 1997;28:537-542.
23. Grond M, Stenzel C, Schmulling S, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544-1549.
24. Koennecke HC, Norh R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 2001;32:1074-1078.
25. Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. Br Med J 2002;325:17.
26. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106-1113.
27. Lindsberg PJ, Soinne L, Roine RO, et al. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke 2003;34:1443-1449.
28. Hand P, Lindley RI, Sandercock P. Do more severe strokes present earlier? An analysis of the first International Stroke Trial. Stroke 2000; 31:2837. Abstract.
29. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29:415-421.
30. Piriyawat P, Smajsova M, Smith MA, et al. Comparison of active and passive surveillance for cerebrovascular disease: the Brain Attack Surveillance in Corpus Christi (BASIC) Project. Am J Epidemiol 2002;156: 1062-1069.
31. Kasner SE, Cucchiara BL, McGarvey ML, Luciano JM, Liebeskind DS, Chalela JA. Modified National Institutes of Health Stroke Scale can be estimated from medical records. Stroke 2003;34:568-570.